(Q36219686)

12 August 2017

1 reference

title

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders (English)

1 reference

12 August 2017

author name string

Dimitri E Grigoriadis

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Therapeutic Targets

12 August 2017

published in

1 reference

12 August 2017

volume

9

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

651-684

1 reference

Epidemiology of women and depression

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Developing novel treatments for mood disorders: accelerating discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Response, partial response, and nonresponse in primary care treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The biochemistry of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The Uptake, Storage, Release and Metabolism of Noradrenaline in Sympathetic Nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The pharmacology of putative early-onset antidepressant strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Antidepressant-induced sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Tianeptine, a selective enhancer of serotonin uptake in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study dagger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Generalised anxiety disorder: treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Nicotinic acetylcholine receptors as targets for antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Mechanism of action of A-85380 in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Modulation of glutamate receptors: strategies for the development of novel antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Role of neurotrophic factors in the etiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Long-term effects of childhood abuse on brain and neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The NPY system in stress, anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Interactions between NPY and CRF in the amygdala to regulate emotionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing factor (CRF) immunoreactivity in hypothalamic and extrahypothalamic nuclei of sheep brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Distribution of corticotropin-releasing factor-like immunoreactivity in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Is corticotropin-releasing factor a mediator of stress responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CRF and CRF receptors: role in stress responsivity and other behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Effects of aspiration versus neurotoxic lesions of the amygdala on emotional responses in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Emotion circuits in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The primate amygdala and the neurobiology of social behavior: implications for understanding social anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Anxiety and affective style: role of prefrontal cortex and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Role of CRF(1) and CRF(2) receptors in fear and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Genetically engineered mice for studies of stress-related clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The therapeutic potential of CRF1 antagonists for anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Molecular biology of the CRH receptors-- in the mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The CRF peptide family and their receptors: yet more partners discovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotrophin-releasing factor receptors: from molecular biology to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Therapeutic potential of CRF receptor antagonists: a gut-brain perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Isolation and characterization of caprine corticotropin-releasing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Isolation and amino acid sequence of corticotropin-releasing factor from pig hypothalami

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and sequence analysis of cDNA for corticotropin-releasing factor precursor from the teleost fish Catostomus commersoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Cloning and characterization of human urocortin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Synthesis and relative potencies of new constrained CRF antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin releasing hormone: therapeutic implications and medicinal chemistry developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Antagonists of the corticotropin releasing factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Pharmacophore development for corticotropin-releasing hormone: new insights into inhibitor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Characterization of the human corticotropin-releasing factor2(a) receptor promoter: regulation by glucocorticoids and the cyclic adenosine 5'-monophosphate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Elevated CSF CRF in suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A Syndrome produced by Diverse Nocuous Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acung through 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Characterization of corticotropin-releasing factor receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Stress, corticotropin-releasing factor, and drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Stress and cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Neuropeptides and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Stress, cytokine patterns and susceptibility to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

CRH in chronic inflammatory stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotrophin-releasing hormone and human parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.651

21 January 2018

Identifiers

DOI

10.1517/14728222.9.4.651

1 reference

12 August 2017

1 reference